Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2024-10-22 Legal Proceedings Report
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Wniesienie powództwa o stwierdzenie nieważności względnie uchylenie uchwały Nadzwyczajnego Walnego Zgromadzenia - Content (PL)
Legal Proceedings Report Classification · 98% confidence The document text is very short (628 characters) and reports that the Management Board received information on October 21, 2024, regarding a lawsuit filed by a Shareholder challenging a resolution (Uchwała nr 4) passed during the Extraordinary General Meeting (Nadzwyczajnym Walnym Zgromadzeniu Akcjonariuszy) on October 14, 2024. This content specifically details a legal challenge against a corporate resolution, which falls under the category of significant lawsuits or regulatory actions. Therefore, the most appropriate classification is Legal Proceedings Report (LTR).
2024-10-22 Polish
Zaproszenie do składania ofert sprzedaży akcji Mercator Medical S.A.
Regulatory Filings Classification · 99% confidence The document is titled "ZAPROSZENIE DO SKŁADANIA OFERT SPRZEDAŻY AKCJI SPÓŁKI MERCATOR MEDICAL S.A." which translates to 'Invitation to Submit Offers for the Sale of Shares of MERCATOR MEDICAL S.A.'. This clearly indicates an offer to buy back shares from existing shareholders, which falls under the category of a tender offer or share repurchase program. The text details the price, schedule, procedure for submitting offers, and the entity inviting the sale (Podmiot Zapraszający - the Company itself). This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K) as it focuses on the transaction mechanics, not periodic financial performance. It is also not a general Regulatory Filing (RNS) because a more specific category exists. It is not a Proxy Statement (PSI) as it is an offer to sell, not a request for a vote.
2024-10-15 Polish
Zaproszenie do składania ofert sprzedaży akcji Emitenta - Content (PL)
Transaction in Own Shares Classification · 99% confidence The document text announces an invitation ('ogłasza zaproszenie') for the sale of the company's shares ('ofert sprzedaży akcji Emitenta') at a fixed price (100.00 PLN per share). This action, where a company buys back its own shares, is explicitly defined as a 'Transaction in Own Shares' or share repurchase. The document states that the full content of the invitation is attached as an annex ('załącznik do niniejszego raportu'), which suggests this filing is the announcement of the transaction rather than the detailed legal filing itself. However, the core subject matter is the share repurchase program. The closest specific category is 'Transaction in Own Shares' (POS). Given the short length and the reference to an attachment, it could potentially be RPA, but the content is a direct announcement of the transaction terms, making POS the most accurate classification for the subject matter.
2024-10-15 Polish
Uchwały podjęte na Nadzwyczajnym Walnym Zgromadzeniu AKcjonariuszy
AGM Information Classification · 98% confidence The document text is titled "Uchwały podjęte na Nadzwyczajnym Walnym Zgromadzeniu" (Resolutions adopted at the Extraordinary General Meeting) and details specific resolutions (Uchwała Nr 1, 2, 3, 4) passed on October 14, 2024, including voting results and objections raised by shareholders. This content directly relates to the formal proceedings and outcomes of a shareholder meeting. The closest matching category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Although this is an Extraordinary General Meeting (EGM), the nature of the document—recording resolutions and voting outcomes—aligns best with AGM-R compared to other options like DVA (which is specifically for *results* declaration, whereas this document details the resolutions themselves) or DEF 14A (Remuneration). Given the context of formal meeting outcomes, AGM-R is the most appropriate classification.
2024-10-14 Polish
Uchwały podjęte na Nadzwyczajnym Walnym Zgromadzeniu - Content (PL)
AGM Information Classification · 95% confidence The document text is very short (501 characters) and explicitly states that the management ('Zarząd') is attaching the content of the resolutions ('treść uchwał podjętych') from an Extraordinary General Meeting ('Nadzwyczajnym Walnym Zgromadzeniu') held on October 14, 2024. This structure—announcing that the actual content (the resolutions) is attached or included—strongly suggests this is an announcement about the meeting results rather than the full, detailed minutes or the primary AGM presentation itself. Since the text focuses on the resolutions passed at a General Meeting, the most appropriate classification is AGM Information (AGM-R), which covers presentations and materials shared during the AGM. Although it could potentially be a DVA (Declaration of Voting Results), AGM-R is broader for general meeting materials.
2024-10-14 Polish
Akcjonariusze posiadający co najmniej 5% głosów na Nadzwyczajnym Walnym Zgromadzeniu - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text is very short (471 characters) and reports on the voting results from an Extraordinary General Meeting (Nadzwyczajnym Walnym Zgromadzeniu) held on October 14, 2024. Specifically, it details the percentage of votes held by the single major shareholder (Anabaza RAIF V.C.I.C. Limited) at that meeting (94.61% of votes present, 65.99% total). This content directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting.
2024-10-14 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.